These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

316 related items for PubMed ID: 6726281

  • 1. Potential value of liposomes containing muramyl dipeptide for augmenting the tumoricidal activity of human alveolar macrophages.
    Sone S, Tachibana K, Shono M, Ogushi F, Tsubura E.
    J Biol Response Mod; 1984; 3(2):185-94. PubMed ID: 6726281
    [Abstract] [Full Text] [Related]

  • 2. Human alveolar macrophages: potentiation of their tumoricidal activity by liposome-encapsulated muramyl dipeptide.
    Sone S, Tsubura E.
    J Immunol; 1982 Sep; 129(3):1313-7. PubMed ID: 7108208
    [Abstract] [Full Text] [Related]

  • 3. Abrogation of species specificity for activation of tumoricidal properties in macrophages by recombinant mouse or human interferon-gamma encapsulated in liposomes.
    Fidler IJ, Fogler WE, Kleinerman ES, Saiki I.
    J Immunol; 1985 Dec; 135(6):4289-96. PubMed ID: 3934281
    [Abstract] [Full Text] [Related]

  • 4. Activation of alveolar macrophage tumoricidal activity and eradication of experimental metastases by freeze-dried liposomes containing a new lipophilic muramyl dipeptide derivative.
    Phillips NC, Moras ML, Chedid L, Lefrancier P, Bernard JM.
    Cancer Res; 1985 Jan; 45(1):128-34. PubMed ID: 3838084
    [Abstract] [Full Text] [Related]

  • 5. Potentiating effect of muramyl dipeptide and its lipophilic analog encapsulated in liposomes on tumor cell killing by human monocytes.
    Sone S, Mutsuura S, Ogawara M, Tsubura E.
    J Immunol; 1984 Apr; 132(4):2105-10. PubMed ID: 6699409
    [Abstract] [Full Text] [Related]

  • 6. Effects of liposome structure and lipid composition on the activation of the tumoricidal properties of macrophages by liposomes containing muramyl dipeptide.
    Schroit AJ, Fidler IJ.
    Cancer Res; 1982 Jan; 42(1):161-7. PubMed ID: 7053846
    [Abstract] [Full Text] [Related]

  • 7. In vitro activation of rat liver macrophages to tumoricidal activity by free or liposome-encapsulated muramyl dipeptide.
    Daemen T, Veninga A, Roerdink FH, Scherphof GL.
    Cancer Res; 1986 Sep; 46(9):4330-5. PubMed ID: 3731091
    [Abstract] [Full Text] [Related]

  • 8. Synergistic activation by lymphokines and muramyl dipeptide of tumoricidal properties in rat alveolar macrophages.
    Sone S, Fidler IJ.
    J Immunol; 1980 Dec; 125(6):2454-60. PubMed ID: 7430635
    [Abstract] [Full Text] [Related]

  • 9. The activation of tumoricidal properties in macrophages of endotoxin responder and nonresponder mice by liposome-encapsulated immunomodulators.
    Fogler WE, Talmadge JE, Fidler IJ.
    J Reticuloendothel Soc; 1983 Mar; 33(3):165-74. PubMed ID: 6834360
    [Abstract] [Full Text] [Related]

  • 10. Synergism between lymphokines and muramyl dipeptide encapsulated in liposomes: in situ activation of macrophages and therapy of spontaneous cancer metastases.
    Fidler IJ, Schroit AJ.
    J Immunol; 1984 Jul; 133(1):515-8. PubMed ID: 6373933
    [Abstract] [Full Text] [Related]

  • 11. Activation of macrophage cytostatic and cytotoxic activity in vitro by liposomes containing a new lipophilic muramyl peptide derivative, MDP-L-alanyl-cholesterol (MTP-CHOL).
    Phillips NC, Moras ML, Chedid L, Petit JF, Tenu JP, Lederer E, Bernard JM, Lefrancier P.
    J Biol Response Mod; 1985 Oct; 4(5):464-74. PubMed ID: 3935756
    [Abstract] [Full Text] [Related]

  • 12. Induction of murine macrophage tumoricidal activity and treatment of experimental pulmonary metastases by liposomes containing lipophilic muramyl dipeptide analogs.
    Phillips NC, Chedid L, Bernard JM, Level M, Lefrancier P.
    J Biol Response Mod; 1987 Dec; 6(6):678-91. PubMed ID: 3450784
    [Abstract] [Full Text] [Related]

  • 13. Synergistic activation by recombinant mouse interferon-gamma and muramyl dipeptide of tumoricidal properties in mouse macrophages.
    Saiki I, Fidler IJ.
    J Immunol; 1985 Jul; 135(1):684-8. PubMed ID: 3923117
    [Abstract] [Full Text] [Related]

  • 14. [Antitumoral activation of rat peritoneal macrophages by muramyl dipeptide in vitro].
    Reisser D, Jeannin JF, Martin F.
    C R Seances Acad Sci III; 1982 Nov 08; 295(8):485-8. PubMed ID: 6819063
    [Abstract] [Full Text] [Related]

  • 15. Involvement of macrophages in the eradication of established metastases following intravenous injection of liposomes containing macrophage activators.
    Fidler IJ, Barnes Z, Fogler WE, Kirsh R, Bugelski P, Poste G.
    Cancer Res; 1982 Feb 08; 42(2):496-501. PubMed ID: 7055801
    [Abstract] [Full Text] [Related]

  • 16. Comparative effect of muramyl dipeptide in vivo and in vitro on the tumoricidal activity of rat peritoneal macrophages.
    Reisser D, Jeannin JF, Lagadec P, Martin F.
    J Biol Response Mod; 1985 Oct 08; 4(5):460-3. PubMed ID: 4078593
    [Abstract] [Full Text] [Related]

  • 17. Design of liposomes to improve delivery of macrophage-augmenting agents to alveolar macrophages.
    Fidler IJ, Raz A, Fogler WE, Kirsh R, Bugelski P, Poste G.
    Cancer Res; 1980 Dec 08; 40(12):4460-6. PubMed ID: 7002293
    [Abstract] [Full Text] [Related]

  • 18. Activation of tumoricidal properties in human blood monocytes by liposomes containing lipophilic muramyl tripeptide.
    Kleinerman ES, Erickson KL, Schroit AJ, Fogler WE, Fidler IJ.
    Cancer Res; 1983 May 08; 43(5):2010-4. PubMed ID: 6831430
    [Abstract] [Full Text] [Related]

  • 19. Differential effects of liposome-incorporation on liver macrophage activating potencies of rough lipopolysaccharide, lipid A, and muramyl dipeptide. Differences in susceptibility to lysosomal enzymes.
    Daemen T, Veninga A, Dijkstra J, Scherphof G.
    J Immunol; 1989 Apr 01; 142(7):2469-74. PubMed ID: 2926140
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.